Anúncio
Anúncio

BIAF

BIAF logo

bioAffinity Technologies, Inc. Common Stock

1.29
USD
Patrocinado
0.00
-0.23%
08 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

1.29

+0.01
+0.54%

Relatórios de Lucros BIAF

Rácio de surpresa positiva

BIAF separação 1 de 6 últimas estimativas.

17%

Próximo Relatório

Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.58M
/
-$2.75
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+9.55%
/
-41.98%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-28.26%
/
-56.35%

bioAffinity Technologies, Inc. Common Stock earnings per share and revenue

On 14 de nov. de 2025, BIAF reported earnings of -4.74 USD per share (EPS) for Q3 25, missing the estimate of -2.75 USD, resulting in a -72.11% surprise. Revenue reached 1.45 milhão, compared to an expected 1.44 milhão, with a 0.47% difference. The market reacted with a -2.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -2.75 USD, with revenue projected to reach 1.58 milhão USD, implying an diminuir of -41.98% EPS, and aumentar of 9.55% in Revenue from the last quarter.
FAQ
For Q3 2025, bioAffinity Technologies, Inc. Common Stock reported EPS of -$4.74, missing estimates by -72.11%, and revenue of $1.45M, 0.47% above expectations.
The stock price moved down -2.13%, changed from $1.88 before the earnings release to $1.84 the day after.
The next earning report is scheduled for 30 de mar. de 2026.
Based on 3 analistas, bioAffinity Technologies, Inc. Common Stock is expected to report EPS of -$2.75 and revenue of $1.58M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio